Medical Dialogues

Do prostate cancer drugs interact with certain anticoagulants to increase bleeding and clotting risks?

In a study of adults with advanced prostate cancer taking androgen-receptor pathway inhibitors and different types of ...
News Medical

Taking anticoagulants alongside prostate cancer drugs does not increase bleeding risk

In a study of adults with advanced prostate cancer taking androgen-receptor pathway inhibitors and different types of anticoagulants, investigators found no evidence of an increase in patients' ...
Medical Xpress

Study finds no evidence that prostate cancer drugs interact with anticoagulants to increase bleeding, clotting risks

In a study of adults with advanced prostate cancer taking androgen-receptor pathway inhibitors and different types of anticoagulants, investigators found no evidence of an increase in patients' ...
Monthly Prescribing Reference

Prostate Cancer Drugs Do Not Interact With DOACs to Increase Bleeding Risk

No increased risk for thrombosis or bleeding seen with concurrent use of enzalutamide, apalutamide, or abiraterone with DOACs. HealthDay News — For patients with prostate cancer, concurrent use of ...
News Medical

Early scans reveal prostate radiotherapy toxicity risk

Daily scans taken during prostate cancer radiotherapy could be repurposed to guide changes to treatment, reducing the risk of side effects, a study suggests. Using AI, scientists found that images ...
EurekAlert!

Routine scans could detect early prostate radiotherapy changes

Daily scans taken during prostate cancer radiotherapy could be repurposed to guide changes to treatment, reducing the risk of side effects, a study suggests. Using AI, scientists found that images ...